Annual report pursuant to Section 13 and 15(d)

Composition of Certain Financial Statement Captions (Details)

v2.4.0.6
Composition of Certain Financial Statement Captions (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Accounts receivable, net:    
Accounts receivable $ 21,636 $ 12,984
Less: allowance doubtful accounts (474) (440)
Accounts receivable, net 21,162 [1] 12,544
Inventories, net:    
Finished products 17,963 11,100
Work in-process 688 277
Raw materials (components) 4,923 2,287
Less: inventory reserve (1,313) (325)
Inventory, net 22,261 [1] 13,339
Prepaid expenses and other current assets:    
Prepaid supplies 443 256
Other receivables 886 288
Prepaid insurance 301 176
Taxes recoverable 1,493 542
Other 4,750 917
Prepaid expenses and other current assets 7,873 [1] 2,179
Property and equipment, net:    
Machinery and equipment 7,984 4,850
Building 3,457 656
Land 2,619 437
Furniture and fixtures 1,908 313
Software 853 630
Leasehold improvements 2,616 309
Less: accumulated depreciation (3,732) (1,837)
Property and equipment, net 16,526 [1] 5,358
Investment properties, net:    
Building 384  
Land 450  
Less: accumulated depreciation (13)  
Investment properties, net 821  
Intangible assets, net:    
Technology 52,810 47,100
Customer relationships 23,088 18,386
In-process research and development 11,546 10,000
Product registrations 9,637 3,895
Tradename 3,746 827
Covenants not to compete 8,662 1,560
Other 367 297
Less: accumulated amortization (14,072) (5,335)
Intangible assets, net 95,784 [1] 76,730
Accrued expenses:    
Income taxes payable 1,614 484
Deferred revenue 1,518 530
Clinical trials 50 7
Customer deposits   255
Professional fees 675 632
Employee benefits 3,319 907
Deferred acquisition payments, net of discount 6,172  
Contingent consideration 5,126  
Other 6,182 2,141
Accrued expenses, net 24,656 4,956
Other long-term liabilities:    
Deferred acquisition payments, net of discount 3,931  
Long-term debt 5,150  
Deferred tax liabilities 9,777 6,863
Other including deferred revenue 380 578
Other long-term liabilities, principally contingent consideration and deferred tax liabilities 34,168 [1] 25,443
CURNA Contingent consideration [Member]
   
Other long-term liabilities:    
Contingent consideration 510 510
FineTech Contingent consideration [Member]
   
Other long-term liabilities:    
Contingent consideration 2,578 4,747
Farmadiet Contingent consideration [Member]
   
Other long-term liabilities:    
Contingent consideration 532  
OPKO Diagnostics Contingent Consideration [Member]
   
Other long-term liabilities:    
Contingent consideration $ 11,310 $ 12,745
[1] As of December 31, 2012, total assets include $5.6 million and total liabilities include $5.5 million related to SciGen (I.L.) Ltd, ("SciGen"), a consolidated variable interest entity. SciGen's consolidated assets are owned by SciGen and SciGen's consolidated liabilities are those as to which there is no recourse against us. Refer to Note 3.